Redmond Cavan M. 4
4 · OncoCyte Corp · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Redmond Cavan M.
Director
Transactions
- Award
Option to purchase common stock
2020-06-17+62,000→ 62,000 totalExercise: $2.38→ Common Stock (62,000 underlying)
Footnotes (1)
- [F1]Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.